COVID-19 Infection Does Not Alter HLA Antibody Reactivity

Abstract

The requirement for immunosuppression in organ transplant recipients, particularly suppression of the T cell response, has made this population especially vulnerable to prolonged and severe infections during the ongoing SARS-CoV-2 pandemic.1 Acknowledgment of this increased risk led to the reduction of deceased-donor organ transplantation, and for many programs, complete cessation of living-donor operations during the early periods of the COVID-19 pandemic.2,3 Nevertheless, for transplant recipients, the risk of contracting viral disease does not exist in a vacuum.